Novartis snags former Astra exec as CFO
Jonathan Symonds, currently managing director of investment banking at Goldman Sachs, will join Novartis on Sept. 1 as deputy chief financial officer (CFO) and as CFO designate, reporting to Raymund Breu, who will retire on March 31, 2010.
Breu will retire at the age of 65, after 35 years of service to Basel, Switzerland-based Novartis.
Symonds spent eight years as CFO at the London-based AstraZeneca, where his position encompassed finance, mergers and acquisitions, strategy, IT, purchasing, business development and licensing, according to Novartis. Before that, he was finance director at Zeneca and previously was a partner at KPMG.
Breu will retire at the age of 65, after 35 years of service to Basel, Switzerland-based Novartis.
Symonds spent eight years as CFO at the London-based AstraZeneca, where his position encompassed finance, mergers and acquisitions, strategy, IT, purchasing, business development and licensing, according to Novartis. Before that, he was finance director at Zeneca and previously was a partner at KPMG.